CN112779173A - High-yield glutathione pichia pastoris strain G3-SF and application thereof - Google Patents

High-yield glutathione pichia pastoris strain G3-SF and application thereof Download PDF

Info

Publication number
CN112779173A
CN112779173A CN202110011361.6A CN202110011361A CN112779173A CN 112779173 A CN112779173 A CN 112779173A CN 202110011361 A CN202110011361 A CN 202110011361A CN 112779173 A CN112779173 A CN 112779173A
Authority
CN
China
Prior art keywords
glutathione
gene
strain
yield
pichia pastoris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110011361.6A
Other languages
Chinese (zh)
Other versions
CN112779173B (en
Inventor
徐国强
许正宏
高宇豪
刘娜
史劲松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202110011361.6A priority Critical patent/CN112779173B/en
Publication of CN112779173A publication Critical patent/CN112779173A/en
Application granted granted Critical
Publication of CN112779173B publication Critical patent/CN112779173B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93Ligases (6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/0102Adenosine kinase (2.7.1.20)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02002Glutamate-cysteine ligase (6.3.2.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y603/00Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/02Acid—amino-acid ligases (peptide synthases)(6.3.2)
    • C12Y603/02003Glutathione synthase (6.3.2.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/22Vectors comprising a coding region that has been codon optimised for expression in a respective host

Abstract

The invention discloses a high-yield glutathione Pichia pastoris strain G3-SF and application thereof, Pichia pastoris GS115 is taken as a host, Scgsh1 and Scgsh2 genes from saccharomyces cerevisiae are heterologously expressed, the excessive production of GSH is obtained, and an engineering bacterium is named as G3; on the basis, heterologous expression is derived from a saccharomyces cerevisiae adenosine kinase Scadk1 gene and a codon-optimized StgshF gene derived from streptococcus sanguis, and aims to enhance energy supply in the fermentation process of engineering bacteria and reconstruct a GSH synthesis path. The highest horizontal yield of glutathione in a shake flask can reach (527.14 +/-17.92) mg/L, and the yield of intracellular glutathione is (19.96 +/-0.05) mg/L/OD. The constructed engineering bacteria G3-SA are fermented in a 5L fermentation tank, the highest yield of the glutathione in 56h is 5950mg/L, the yield of the intracellular glutathione is 25.54mg/L/OD, and a new idea is provided for the industrial production of the GSH.

Description

High-yield glutathione pichia pastoris strain G3-SF and application thereof
Technical Field
The invention belongs to the technical field of biosynthesis, and particularly relates to a high-yield glutathione pichia pastoris strain G3-SF and application thereof.
Background
Glutathione is a tripeptide active substance widely present in animals, plants and microorganisms, and has the effects of protecting and regulating intracellular redox balance. The molecular weight of the compound is 307.33, the compound is composed of glutamic acid, cysteine and glycine, the content of the compound in various organisms is different, and the content of the compound in yeast and animal viscera is higher. GSH also plays a wide role in the clinical field, and has significant efficacy in liver diseases, kidney diseases and cardiovascular diseases.
GSH is primarily characterized by having one gamma amide bond and one sulfhydryl group. In most procaryotic and eucaryotic organisms, glutamylcysteine is generated by glutamic acid and cysteine under the action of GSH1 in the first step, and then the product is reacted with glycine under the action of GSH2 to generate GSH, wherein the enzyme in the first step is a key enzyme for generating GSH and is inhibited by the feedback of the product, the two steps of enzyme are ATP dependent, and 1 molecule of ATP is consumed in the reaction.
Methods for synthesizing GSH have been reported to be chemical synthesis, enzymatic conversion, and fermentation. The chemical synthesis method adopts three raw materials and utilizes a chemical process to synthesize the GSH, so the cost is high and the GSH has pollution to the environment. The enzymatic method adopts three raw materials, ATP and enzyme reaction to generate GSH, and the core of the method is to screen out synthetase with high activity, but the cost is high, and most of the synthetases are researched at present. The fermentation method is that microorganisms use cheap raw materials to grow and accumulate high-concentration GSH, and then the GSH is separated and purified in the next step. Low cost, high purity and no pollution, and is the main method for producing GSH at present.
For this reason, attempts have been made to achieve the production of GSH using various microorganisms. In this regard, previous studies have often employed mutagenesis or genetic engineering to increase enzyme activity, or to increase precursor utilization by optimizing fermentation conditions. Since the yeast has a high content of GSH and a clear genetic background, it is often used as an excellent host for the production of GSH. At present, the main industrial production is mainly fermentation method, and the production host is yeast, large intestine and the like. The pichia pastoris is in a state of food-safe microorganisms, exogenous expression is mainly integrated, and an expensive inducer is not needed, so that the pichia pastoris becomes an excellent host for producing exogenous proteins and other biological products by high-density fermentation.
Three factors limiting the fermentation yield of GSH are the activity of GSH synthase, the supply of cysteine and ATP. Cysteine can be supplemented by exogenous addition, but excess cysteine can result in insufficient supply of ATP during synthesis.
Alfafara et al found cysteine (Cys) to be a key amino acid for increasing GSH. However, when high-density fermentation is carried out, Cys synthesized by cells through metabolism is far from meeting the requirement of GSH synthesis. Exogenous addition of Cys is therefore an effective strategy and indeed also leads to large scale production of GSH. However, when Cys is added in excess, ATP, which acts as an energy carrier, is made the limiting factor for GSH production. To solve this problem, Liang et al increase GSH yield by 11% by directly adding ATP, which is an expensive raw material, and cannot be scaled up. As another example, Wang et al studied that citrate was used as a co-energy substrate to promote the production of NADH, and further strengthened the production of ATP by an electron transport chain, the SAM and GSH yields of the strain and the co-production yield thereof were improved by 27.5%, however, this method could not improve enough ATP to meet the production requirement of high GSH.
Increasing the supply of ATP using traditional metabolic engineering is a good strategy for the performance of energy-intensive reactions. It is reported that expression of VHB protein in Pichia pastoris increases oxygen uptake capacity of the bacteria, and further increases ATP supply, resulting in a 19-fold increase in SAM yield compared to the control. Tani et al found that ADK from saccharomyces cerevisiae was the rate-limiting step in the conversion of AMP to ATP, and later confirmed in Harit's study of SAM production using pichia pastoris.
In summary, ATP is a main limiting factor for glutathione synthesis, and how to increase ATP supply and effectively increase glutathione yield is a technical problem that needs to be solved in the field.
Disclosure of Invention
The purpose of the invention is as follows: research shows that ATP addition or ATP metabolism improvement and regeneration promotion have a promoting effect on glutathione synthesis, but the problems of high cost or limited effect exist. In order to overcome the problems and the defects in the prior art, the invention provides the high-yield glutathione Pichia pastoris strain G3-SF and the application thereof, enhances the synthesis of intracellular GSH, and has universal significance for promoting the synthesis of glutathione or the production of other energy-consuming products.
The technical scheme is as follows: in order to achieve the purpose, the invention adopts the technical scheme that:
the invention aims to provide a high-yield glutathione Pichia pastoris strain G3-SF, which takes Pichia pastoris as a host, heterologously expresses a glutathione synthetase Scgsh1 gene, a Scgsh2 gene, an adenosine kinase Scadk1 gene and a streptococcus sanguis-derived bifunctional enzyme StgshF gene from saccharomyces cerevisiae, and an obtained engineering bacterium is named as Pichia pastoris strain G3-SF.
Further, the Pichia pastoris GS115 is selected from Pichia pastoris, and the strain is purchased from an vast ling plasmid platform.
Further, the nucleotide sequences of the glutathione synthetase Scgsh1 and Scgsh2 genes, the adenosine kinase Scadk1 gene and the bifunctional enzyme StgshF gene are respectively shown as SEQ.NO.01-SEQ.NO. 04.
The invention also aims to provide a construction method of the high-yield glutathione Pichia pastoris strain G3-SF: taking pichia as a host, firstly heterologously expressing glutathione synthetase Scgsh1(Gene ID:853344) and Scgsh2(Gene ID:854108) genes from saccharomyces cerevisiae, and obtaining an engineering bacterium named G3; and G3 is taken as a host, and the adenosine kinase Scadk1(Gene ID:851812) Gene from saccharomyces cerevisiae and the StgshF (Gene ID: GU138096) Gene from streptococcus sanguis with optimized codons are expressed in a heterologous way, so that the obtained engineering bacterium is named as a pichia pastoris strain G3-SF.
Further, the concrete method is that pGAPZA is used as initial plasmid, BglII and BamHI are used for enzyme digestion, and the insert is insertedThe fragment containing Xba I was inserted therein, and the resulting plasmid was named pGAPZT. Inserting P between BglII and Xba I of pGAPZTAOX1And (4) sequencing. The Scadk1 Gene (Gene ID:851812) was obtained BY S.cerevisiae BY4741 genomic PCR amplification, and the StgshF (Gene ID: GU138096) Gene was synthesized BY Kingzhi Biotechnology Ltd and codon-optimized. The obtained fragments are respectively connected in pGAPZT, and expression cassettes of two genes are obtained. Then, the StgshF gene expression cassette is connected behind the Scadk1 gene expression cassette in series by the principle of ligase, and is linearized and transferred to a G3 strain by SacI, and the obtained strain is screened by a YPD plate containing 2mg/L Zeocin, and the obtained strain is named as G3-SF.
Furthermore, in the fermentation process of the heterologous expression of the adenosine kinase Scadk1 gene and the bifunctional enzyme gene StgshF, 4g/L of sodium citrate is exogenously added when the fermentation time is 15-16 h.
Another objective of the invention is to provide a plasmid obtained in the process of the construction method of the high-yield glutathione Pichia pastoris strain G3-SF.
It is another object of the present invention to provide a gene encoding the high-yielding Pichia glutathione yeast strain G3-SF according to any one of claims 1 to 3.
The invention also aims to provide a method for preparing glutathione, which adopts the high-yield glutathione Pichia pastoris strain G3-SF or the high-yield glutathione Pichia pastoris strain G3-SF constructed by the method to synthesize glutathione by a fermentation method.
Another object of the present invention is to provide glutathione produced by the above method.
Has the advantages that: compared with the prior art, the high-yield glutathione pichia pastoris strain G3-SF and the application thereof provided by the invention have the following advantages: the invention takes pichia pastoris GS115 as a host, heterologously expresses Scgsh1 and Scgsh2 genes from saccharomyces cerevisiae, obtains the overproduction of GSH, and names engineering bacteria as G3; on the basis, heterologous expression is from saccharomyces cerevisiae adenosine kinase Scadk1 and StgshF gene obtained by Streptococcus sanguis after codon optimization, and aims to enhance energy supply and reconstruct metabolic pathway in the fermentation process of engineering bacteria. At present, the highest yield of the glutathione in a shake flask can reach (527.14 +/-17.92) mg/L, and the yield of the intracellular glutathione is (19.96 +/-0.05) mg/L/OD. The constructed engineering bacteria G3-SA are fermented in a 5L fermentation tank, the highest yield of the glutathione in 56h is 5950mg/L, and the yield of the intracellular glutathione is 25.54mg/L/OD, so that a new idea is provided for the industrial production of the GSH.
Drawings
FIG. 1 is an electrophoretogram constructed from the G3 strain in example 1;
wherein, M in a is 5kb marker; 1,2, PCR amplification of Scgsh1 gene;
m in b is 5kb marker; 1,2, PCR amplification of Scgsh2 gene;
m in c is 5kb marker; 1,2, extracting genome verification primer verification for G2 strain (G2 is constructed engineering bacteria which take pichia pastoris GS115 as a host and only express Scgsh1 gene);
m in d is 5kb marker; 1,2, extracting genome verification primer verification for G3 strain.
FIG. 2 is a graph showing the electrophoretic verification of G3-SF in example 2; m: DL10000 Marker; 1.2, 3, 4, 5: and (5) carrying out PCR verification on the genome of the engineering bacteria.
FIG. 3 is a graph showing the results of G3-SF shake flask fermentation in example 3;
FIG. 4 is a graph showing the change in intracellular ATP content in the fermentation of the G3-SF strain in example 3.
FIG. 5 shows the results of fermentation of G3-SF in a 5L fermentor in example 4;
FIG. 6 is a graph showing the results of shake flask fermentation of the G3 strain in comparative example 1; wherein, a-biomass, b-GSH concentration, c-GSH yield, d-strain fermentation result chart when amino acid precursor is added.
FIG. 7 is a schematic diagram of the method of the present invention.
Detailed Description
According to the invention, the synthesis path of glutathione is enhanced by heterologously expressing Scgsh1 and Scgsh2 in Pichia pastoris, the constructed strain is named as G3, and then the Scadk1 gene from Saccharomyces cerevisiae and the StgshF gene from Streptococcus sanguis are heterologously expressed, so that endogenous metabolic modification is carried out on host cells, and the supply of intracellular ATP is effectively enhanced and the GSH synthesis path is reconstructed by combining the addition of exogenous sodium citrate, thereby further enhancing the synthesis of intracellular GSH.
The invention is further described with reference to the following figures and examples.
Examples
The present invention will be better understood from the following examples. However, those skilled in the art will readily appreciate that the specific material ratios, process conditions and results thereof described in the examples are illustrative only and should not be taken as limiting the invention as detailed in the claims.
Example 1: construction of G3 Strain
Construction of the P3 plasmid: this patent is constructed with PGAPIs a promoter, TAOX1Is a constitutive expression strain of terminator. Firstly, amplifying P on genome by using GAP-F/GAP-R as primerGAPA promoter sequence. pPIC 3.5K was cleaved with SacI and BamHI to remove PAOX1Fragment combination of PGAPThe plasmid constitutively expressed was obtained by sequence substitution and named pPICKT. Genome of S.cerevisiae BY4741 is taken as a template, GSH1F/GSH1R and GSH2F/GSH2R are respectively PCR amplified to obtain target gene Scgsh1 and Scgsh2 fragments (the gene sequences are shown as SEQ. NO.01-SEQ. NO. 02) which are respectively connected to pPICKT to form P1 and P2 plasmids, and the construction is carried out after the verification BY YZGF/YZGR. Then G1F/G1R and TF/TR were used to amplify PGAP-Scgsh1 and T on P1 plasmid, respectivelyAAnd the ox1 fragment is connected into a P2 plasmid by adopting a Novozam C113 multi-fragment homologous recombination and connection kit to obtain a plasmid pP-PGAP-Scgsh1-Scgsh2 which simultaneously contains expression units of Scgsh1 and Scgsh2, namely a P3 plasmid. And verified by a verified primer YZGGF/YZGGR, the construction can be realized.
Construction of the G3 strain: the plasmid construction processes are all transformed into escherichia coli JM109 competent cells, screening is carried out on an ampicillin (Amp) LB resistance plate containing 100mg/L, and the obtained transformant is verified by colony PCR and sequenced to obtain the correct transformant. After plasmids pPICKT, P1 and P3 were all linearized with SalI, the linearized plasmids were transformed into Pichia pastoris by electrotransformation according to the manual (Invitrogen), spread on MD histidine-containing deficient plates, and incubated at 30 ℃ for 2-3 d. The grown colonies are spotted into high-mass concentration G418(4mg/mL), and the target strain with high copy gene factor can be obtained after the grown larger colonies are subjected to genome verification, as shown in FIG. 1.
Example 2: construction of G3-SF Strain
Construction of pGAPZT-Scadk1-StgshF plasmid: in the research, pGAPZA is used as a starting plasmid, the starting plasmid is modified, the modified plasmid is named as pGAPZT, and the plasmid realizes the tandem expression of multiple genes in a mode of isocaudarner. Firstly, ZXF/ZXR is used as a primer, pGAPZA is used as a template to carry out PCR amplification, so that the front end of a promoter of the recovered product X fragment is provided with Xba I, and the tail end of a terminator is provided with Nhe I enzyme cutting site. pGAPZA was cleaved with Bgl II and BamHI to remove the intermediate fragment, and the X fragment was substituted to obtain a plasmid containing the isocaudarner enzyme, which was designated pGAPZX. Using ZTF/ZTR as upstream and downstream primers and pPICZA as template to perform PCR amplification to obtain PAOX1Cutting the pGAPZX vector by Bgl II and Xba I and reacting with PAOX1Fragment ligation to obtain a fragment containing PAOX1The plasmid of (1), named pGAPZT, which can integrate expression cassettes of single or multiple genes of interest into chromosomal PAOX1The position was verified by primers YZF/YZR and used. And amplifying the codon-optimized StgshF fragment (the primer sequence is shown as SEQ. NO. 04) by using a GSHFF/GSHFR primer, and connecting the product to PGAPZT by using a Novozan C113 kit to obtain an expression plasmid pGAPZT-StgshF. And respectively taking the genome of S.cerevisiae BY4741 as a template and SADKF/SADKR as a primer to amplify the target gene Scadkk 1 BY PCR, and connecting the target gene Scadkk 1 to PGAPZT BY using a C113 kit to obtain an expression plasmid pGAPZT-Scadk 1. And amplifying by taking SFF/SFR as a primer and pGAPZT-StgshF as a template to obtain an expression cassette containing StgshF, respectively connecting the expression cassette to a pGAPZT-Scadk1 plasmid which is cut by Nhe I and BamHI by utilizing T4 ligase to obtain a pGAPZT-Scadk1-StgshF recombinant plasmid, and verifying by using a primer YZ2F/YZ2R to construct the following plasmid.
Construction of G3-SF Strain: the plasmid construction processes are all transformed into escherichia coli JM109 competent cells, screening is carried out on a low-salt LB resistant plate containing 25 mug/mL Zeocin, and the obtained transformant is subjected to colony PCR verification and Tenglin biotechnology limited company for sequencing, so that the correct transformant is obtained. The G3 strain was made competent cells, the above recombinant plasmid pGAPZT-Scadk1-StgshF was linearized with SacI, and the plasmid was electrotransferred to the Pichia pastoris G3 strain according to the manual (Invitrogen) to obtain G3-SF. And coating the electrotransformation product in a YPDZ culture medium, and incubating for 2-3 days at 30 ℃. The grown colony is spotted in YPD medium containing high-quality Zeocin (2mg/mL), and after genome verification of the grown recombinant strain, the target strain containing high copy gene factor can be obtained, as shown in figure 2.
Example 3: G3-SF strain shake flask fermentation and intracellular ATP content change
The shake flask level fermentation medium is a YPD medium comprising: 20g/ml of glucose, 10g/ml of yeast powder and 20g/ml of peptone.
And (3) shaking flask fermentation: both the seed medium, i.e., YPD medium and the fermentation medium, were YPD medium. The strain is selected from a glycerol tube to be streaked on a YPD plate, the strain is cultured for 2-3 d at 30 ℃, a single colony grown is selected to be a shake flask containing 10mL of seed culture medium, the strain is cultured for 16-18 h at 30 ℃, then the strain is inoculated into a fermentation culture medium at a proper concentration and cultured for 30h at 220rpm, and mixed liquor with the concentrations of 10mM glutamic acid, 10mM cysteine and 10mM glycine is added at the beginning. After fermenting for 30h, the thalli are collected, and the supernatant is used for measuring ethanol, glycerol and glucose. And (3) shaking and incubating for 2h by using 40% ethanol solution at 220rpm, and centrifuging to obtain supernatant containing high-concentration GSH. Another sample is centrifuged and then is subjected to ultrasonic crushing, and the content of intracellular ATP is determined by adopting a Biyuntian ATP detection kit.
The results of shake flask fermentation are shown in FIG. 3, and the fermentation curve of G3-SF is determined, the strain enters logarithmic growth phase within 5h, and enters plateau phase within 20h, and the carbon source is completely exhausted within 20 h. During this time, the levels of glycerol and ethanol by-products were determined, and the glycerol levels were always low during fermentation and therefore not as a by-product of GSH fermentation. Ethanol is accumulated more in the early stage of fermentation, and when the carbon source is exhausted, the ethanol is used as the carbon source to continue fermentation and be exhausted. The yield reached the highest at 30h and then began to decline, probably because the strain activity decreased and the intracellular associated enzyme activity decreased as the fermentation time increased. And GSH degrading enzyme exists in cells to degrade the synthesized GSH. The yield of intracellular GSH is highest at 30h and is (453.26 +/-18.33) mg/L, the yield of intracellular GSH is (18.71 +/-0.43) mg/L/OD, then the change of intracellular ATP content after each recombinant strain and the addition of sodium citrate is researched, and the result is shown in the following figure 4, the intracellular ATP content of the strains within 16-28h after the addition of the sodium citrate is higher than that of a control, because the addition of the sodium citrate and the metabolic modification enhance the regeneration of intracellular ATP, thereby improving the intracellular ATP content. The ATP content reaches the highest value within 20h, and then rapidly decreases, probably because the thallus grows into a plateau stage in the period, and then a large amount of GSH is synthesized, and a large amount of ATP is consumed.
Example 4: fermentation in G3-SF strain fermentation tank
100L fermenter Medium (g/L): glucose 50, yeast powder 5, (NH4)2SO4 11,K2HPO4 7,MgSO 4 5,CaCl2 0.5,KCl 0.5。
Fermentation in a fermentation tank: the seed culture medium is cultured for 16-18 h, and the seed culture medium is inoculated into a 100L fermentation tank according to the inoculation amount of 10%. When the pH of the culture medium is reduced to 5.5, 50% ammonia water is fed in to maintain the pH of the fermentation process at 5.5 all the time. 10mL of PTM1 was contained in each liter of medium, and when the sugar in the initial medium decreased to 5g/L, 700g/L of glucose was supplemented to keep the ethanol concentration below 3 g/L. When fermenting for 16h, 4g/L sodium citrate is added. When the fermentation time reaches 48h, the mixture of 25mM glutamic acid, 25mM cysteine and 25mM glycine is fed to the final concentration. Sampling at regular time, and measuring the biomass, the glutathione concentration, the glycerol, the reducing sugar and the ethanol concentration.
As shown in FIG. 5, the fermentation result of the fermentor is that the biomass of G3-SF strain is in the late logarithmic growth phase at 40h and reaches the stationary growth phase at 48h, the biomass OD600 reaches 243.0, which is 9.20 times higher than that of biomass OD600(26.4) in the flask fermentation level, and simultaneously the glucose is rapidly consumed at 16h, and the residual amount is 0.33G/L. GSH accumulated as a primary metabolite with the growth of the cells and reached 960mg/L at 44h before the amino acid precursor mixture was dosed. When the amino acid solution is fed at the moment, the synthesis efficiency of the glutathione is rapidly increased, the yield of the GSH reaches 5950mg/L at the maximum at 56h, the yield is increased by 11.28 times compared with the highest yield (527.14 +/-17.92) mg/L at the shake flask level, and the yield of the intracellular GSH is 25.54 mg/L/OD.
Comparative example 1: shaking flask fermentation of G3 strain
The procedure is as in example 4, except that the strain added is the G3 strain.
The result of shake flask fermentation is shown in fig. 6, the growth of a control strain GS115 is lower than that of an engineering bacterium, and the transfer of G1 and G2 genes hardly affects the growth, wherein G1 is a blank control group engineering bacterium which is a constructed engineering bacterium which takes pichia pastoris GS115 as a host and is transformed to express an empty plasmid; g2 is an engineering bacterium which is constructed by taking pichia pastoris GS115 as a host and only expresses Scgsh1 gene. G3 strain had a 30h GSH of 141.96mg/L and the yield was 2.62 fold higher compared to the control. In order to improve the synthesis efficiency of GSH, a mixed solution of glycine, cysteine and glutamic acid with the final concentration of 10mM is added when the fermentation is carried out for 0 h. From FIG. 6(d), it can be seen that the addition of the amino acid precursor has a certain inhibitory effect on the growth of the strain, which may be caused by the toxic effect of cysteine in the precursor on the strain, but the addition of the precursor does greatly improve the ability of the bacteria to synthesize GSH. At 30h of fermentation, GSH production was (302.27. + -. 5.06) mg/L and intracellular yield was (11.79. + -. 0.35) mg/L/OD, but this level was not very high and was suspected to be due to poor synthetase capacity or insufficient intracellular energy supply.
In conclusion, compared with the G3 strain, the invention further heterologously expresses the Scadk1 gene from the saccharomyces cerevisiae and the StgshF gene from the streptococcus sanguis, and really achieves the purpose of enhancing the energy supply in the fermentation process, compared with the shake flask fermentation level of the G3 strain, the highest shake flask level yield of the glutathione of the invention can reach (527.14 +/-17.92) mg/L, and the yield of the intracellular glutathione is (19.96 +/-0.05) mg/L/OD. The constructed engineering bacteria G3-SA are fermented in a 5L fermentation tank, the highest yield of the glutathione in 56h is 5950mg/L, and the yield of the intracellular glutathione is 25.54 mg/L/OD. The results of both shaking flask fermentation and fermentation tank fermentation are far higher than the existing technical level, and especially the fermentation capacity of a 5L fermentation tank is greatly improved, so that a new idea is provided for the industrial production of GSH.
TABLE 1 primer sequences
Figure BDA0002885292320000081
Figure BDA0002885292320000091
The above description is only of the preferred embodiments of the present invention, and it should be noted that: it will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the principles of the invention and these are intended to be within the scope of the invention.
Sequence listing
<110> university of south of the Yangtze river
<120> high-yield glutathione pichia pastoris strain G3-SF and application thereof
<141> 2021-01-06
<160> 4
<170> SIPOSequenceListing 1.0
<210> 1
<211> 2037
<212> DNA
<213> Scgsh1 Saccharomyces cerevisiae BY4741
<400> 1
atgggactct tagctttggg cacgcctttg cagtggtttg agtctaggac gtacaatgaa 60
cacataaggg atgaaggtat cgagcagttg ttgtatattt tccaagctgc tggtaaaaga 120
gacaatgacc ctcttttttg gggagacgag cttgagtaca tggttgtaga ttttgatgat 180
aaggagagaa attctatgct cgacgtttgc catgacaaga tactcactga gcttaatatg 240
gaggattcgt ccctttgtga ggctaacgat gtgagttttc accctgagta tggccggtat 300
atgttagagg caacaccagc ttctccatat ttgaattacg tgggtagtta cgttgaggtt 360
aacatgcaaa aaagacgtgc cattgcagaa tataagctat ctgaatatgc gagacaagat 420
agtaaaaata acttgcatgt gggctccagg tctgtccctt tgacgctgac tgtcttcccg 480
aggatgggat gccccgactt tattaacatt aaggatccgt ggaatcataa aaatgccgct 540
tccaggtctc tgtttttacc cgatgaagtc attaacagac atgtcaggtt tcctaacttg 600
acagcatcca tcaggaccag gcgtggtgaa aaagtttgca tgaatgttcc catgtataaa 660
gatatagcta ctccagaaac ggatgactcc atctacgatc gagattggtt tttaccagaa 720
gacaaagagg cgaaactggc ttccaaaccg ggtttcattt atatggattc catgggtttt 780
ggcatgggct gttcgtgctt acaagtgacc tttcaggcac ccaatatcaa caaggcacgt 840
tacctgtacg atgcattagt gaattttgca cctataatgc tagccttctc tgccgctgcg 900
cctgctttta aaggttggct agccgaccaa gatgttcgtt ggaatgtgat atctggtgcg 960
gtggacgacc gtactccgaa ggaaagaggt gttgcgccat tactacccaa atacaacaag 1020
aacggatttg gaggcattgc caaagacgta caagataaag tccttgaaat accaaagtca 1080
agatatagtt cggttgatct tttcttgggt gggtcgaaat ttttcaatag gacttataac 1140
gacacaaatg tacctattaa tgaaaaagta ttaggacgac tactagagaa tgataaggcg 1200
ccactggact atgatcttgc taaacatttt gcgcatctct acataagaga tccagtatct 1260
acattcgaag aactgttgaa tcaggacaac aaaacgtctt caaatcactt tgaaaacatc 1320
caaagtacaa attggcagac attacgtttt aaacccccca cacaacaagc aaccccggac 1380
aaaaaggatt ctcctggttg gagagtggaa ttcagaccat ttgaagtgca actattagat 1440
tttgagaacg ctgcgtattc cgtgctcata tacttgattg tcgatagcat tttgaccttt 1500
tccgataata ttaacgcata tattcatatg tccaaagtat gggaaaatat gaagatagcc 1560
catcacagag atgctatcct atttgaaaaa tttcattgga aaaaatcatt tcgcaacgac 1620
accgatgtgg aaactgaaga ttattctata agcgagattt tccataatcc agagaatggt 1680
atatttcctc aatttgttac gccaatccta tgccaaaaag ggtttgtaac caaagattgg 1740
aaagaattaa agcattcttc caaacacgag agactatact attatttaaa gctaatttct 1800
gatagagcaa gcggtgaatt gccaacaaca gcaaaattct ttagaaattt tgtactacaa 1860
catccagatt acaaacatga ttcaaaaatt tcaaagtcga tcaattatga tttgctttct 1920
acgtgtgata gacttaccca tttagacgat tcaaaaggtg aattgacatc ctttttagga 1980
gctgaaattg cagaatatgt aaaaaaaaat aagccttcaa tagaaagcaa atgttaa 2037
<210> 2
<211> 1476
<212> DNA
<213> Scgsh2(Saccharomyces cerevisiae BY4741)
<400> 2
atggcacact atccaccttc caaggatcaa ttgaatgaat tgatccagga agttaaccaa 60
tgggctatca ctaatggatt atccatgtat cctcctaaat tcgaggagaa cccatcaaat 120
gcatcggtgt caccagtaac tatctatcca accccaattc ctaggaaatg ttttgatgag 180
gccgttcaaa tacaaccggt attcaatgaa ttatacgccc gtattaccca agatatggcc 240
caacctgatt cttatttaca taaaacaact gaagcgttag ctctatcaga ttccgagttt 300
actggaaaac tgtggtctct ataccttgct accttaaaat ctgcacagta caaaaagcag 360
aattttaggc taggtatatt tagatcagat tatttgattg ataagaaaaa gggtactgaa 420
cagattaagc aagtcgagtt taatacagtg tcagtgtcat ttgcaggcct tagcgagaaa 480
gttgatagat tgcactctta tttaaatagg gcaaacaagt acgatcctaa aggaccaatt 540
tataatgatc aaaatatggt catttctgat tcaggatacc ttttgtctaa ggcattggcc 600
aaagctgtgg aatcgtataa gtcacaacaa agttcttcta caactagtga tcctattgtc 660
gcattcattg tgcaaagaaa cgagagaaat gtgtttgatc aaaaggtctt ggaattgaat 720
ctgttggaaa aattcggtac caaatctgtt aggttgacgt ttgatgatgt taacgataaa 780
ttgttcattg atgataaaac gggaaagctt ttcattaggg acacagagca ggaaatagcg 840
gtggtttatt acagaacggg ttacacaacc actgattaca cgtccgaaaa ggactgggag 900
gcaagactat tcctcgaaaa aagtttcgca ataaaggccc cagatttact cactcaatta 960
tctggctcca agaaaattca gcaattgttg acagatgagg gcgtattagg taaatacatc 1020
tccgatgctg agaaaaagag tagtttgtta aaaacttttg tcaaaatata tcccttggat 1080
gatacgaagc ttggcaggga aggcaagagg ctggcattaa gtgagccctc taaatacgtg 1140
ttaaaaccac agcgggaagg tggcggaaac aatgtttata aagaaaatat tcctaatttt 1200
ttgaaaggta tcgaagaacg tcactgggat gcatatattc tcatggagtt gattgaacca 1260
gagttgaatg aaaataatat tatattacgt gataacaaat cttacaacga accaatcatc 1320
agtgaactag gaatttatgg ttgcgttcta tttaacgacg agcaagtttt atcgaacgaa 1380
tttagtggct cattactaag atccaaattt aatacttcaa atgaaggtgg agtggcggca 1440
ggattcggat gtttggacag tattattctt tactag 1476
<210> 3
<211> 669
<212> DNA
<213> Scadk1
<400> 3
atgtctagct cagaatccat tagaatggtc ctaattggcc cacctggtgc cggtaaaggt 60
actcaagctc caaatttgca agagcgtttc catgccgctc acttggccac tggtgacatg 120
ttgagatctc aaatcgcaaa gggcactcaa ttaggtttgg aagcaaagaa aattatggac 180
caaggtggtt tagtctctga tgacattatg gttaacatga tcaaggatga attgaccaac 240
aatccagctt gtaagaatgg gttcatcttg gacggtttcc caagaaccat tcctcaggct 300
gaaaaattgg accaaatgtt gaaagaacaa ggaactcctt tggaaaaagc catcgaattg 360
aaggttgatg atgaattgtt ggttgccaga attaccggta gattaattca cccagcctct 420
ggcagatcct accacaagat ctttaaccca ccaaaggaag acatgaagga tgacgtcacc 480
ggtgaagctt tagttcaaag atctgatgac aatgcagacg ccttgaagaa gagattagct 540
gcttaccatg ctcaaaccga accaattgtt gacttttaca aaaagaccgg tatctgggct 600
ggtgttgatg cttcccaacc tcctgctact gtttgggctg acatcttgaa caagctaggt 660
aaggattaa 669
<210> 4
<211> 2265
<212> DNA
<213> StgshF
<400> 4
atgacattaa accaacttct tcaaaaactg gaagctacca gccctattct ccaagctaat 60
tttggaatcg agcgcgagag tctacgtgtc gataggcaag gacaactggt gcatacacct 120
cacccatcct gtctaggagc tcgtagtttc cacccctata ttcagactga tttttgcgag 180
tttcagatgg aactcatcac accagttgcc aaatctacta ctgaggctcg ccgatttctg 240
ggagctatta ctgatgtagc tggccgctct attgctacag acgaggttct ctggccttta 300
tccatgccac ctcgtctaaa ggcagaggag attcaagttg ctcaactgga aaatgacttc 360
gaacgccatt atcgtaacta tttggctgaa aaatacggaa ctaaactaca agctatctca 420
ggtatccact ataatatgga actgggtaaa gatttagttg aggccttgtt ccaagaaagt 480
ggtcagaccg atatgattgc cttcaaaaac gccctctatc ttaagctggc tcagaactac 540
ttgcgctacc gttgggtgat tacctatctc tttggggcct cacccatcgc cgaacaaggt 600
ttctttgacc aggaagttcc agaacctgtg cgttccttcc gtaacagtga ccacggctat 660
gtcaataagg aagagattca agtatccttt gtaagtctag aagattatgt ctcagccatt 720
gaaacctata tcgaacaagg agatttgaat gcagagaaag aattttactc agctgttcgt 780
ttccgtggac aaaaggttaa tcgttccttc cttgacaaag gaatcaccta cctagagttc 840
cgtaatttcg accttaaccc ttttgagcgt atcggtatta gtcagactac tatggacact 900
gtgcacttac tcattttagc cttcctttgg cttgatagcc ctgaaaatgt cgaccaagct 960
cttgcacaag gccacgcgtt aaatgagaaa attgccctct ctcatcctct agaacctcta 1020
ccttcggagg ctaaaactca ggacattgta actgccctag accaactggt gcaacacttt 1080
ggacttggtg actatcatca agatctggtt aagcaagtta aggcagcctt tgcggatcca 1140
aatcaaacgc tctctgccca gctcttaccc tatatcaaag acaaatctct agccgaattt 1200
gctttaaaca aggctcttgc ctatcatgat tacgactgga ctgcccacta tgctctcaag 1260
ggctatgaag agatggaact ctccacccag atgttgctct ttgatgccat ccaaaagggg 1320
attcactttg aaatattgga tgagcaagat caattcctaa aactttggca ccaagaccat 1380
gttgaatacg tcaaaaacgg taacatgacc tcaaaagaca actacgtggt tccccttgct 1440
atggctaata agaccgtaac caagaagatt ctagcagatg ctggctttcc agttccttca 1500
ggagacgaat ttaccagtct tgaggaagga cttgcctact accctcttat caaggataag 1560
caaattgttg tcaaacccaa gtcaactaac tttggtctgg gaatttccat tttccaagaa 1620
cctgccagtc ttgacaacta tcaaaaagcc cttgaaattg ctttcgcaga agatacctct 1680
gtccttgttg aagaatttat tccaggaacc gaataccgtt tcttcatctt ggatgggcgt 1740
tgtgaggctg ttcttctgcg tgtcgctgcc aatgttattg gtgatggcaa acacaccatt 1800
cgtgaactag tcgctcagaa aaatgctaat ccattgcgtg gccgtgatca ccggtcacct 1860
ctggaaatca ttgagctagg agacatcgaa caactaatgt tagctcaaca gggttacaca 1920
cctgatgata ttctcccaga aggaaaaaag gtcaatctgc gtcgtaattc caacatctct 1980
acaggtggtg actctattga tatcactgag accatggatt cctcttacca agaattagcc 2040
gcagccatgg caactagcat gggcgcctgg gcttgcgggg ttgatctgat aattccagat 2100
gaaactcaaa ttgccaccaa ggaaaatcct cattgcacct gcattgagct caactttaac 2160
ccttcgatgt atatgcacac ctactgtgct gagggtcctg gccaagctat cactactaaa 2220
atcctagata aactttttcc agaaatagtg gctggtcaaa cttaa 2265

Claims (10)

1. A high-yield glutathione Pichia pastoris strain G3-SF, which is characterized in that: pichia pastoris is taken as a host, and a glutathione synthetase Scgsh1 gene, a Scgsh2 gene, an adenosine kinase Scadk1 gene and a streptococcus sanguis-derived bifunctional enzyme StgshF gene which are derived from saccharomyces cerevisiae are heterologously expressed, so that the obtained engineering bacterium is named as a Pichia pastoris strain G3-SF.
2. The high yielding pichia glutathione strain G3-SF according to claim 1, wherein: the Pichia pastoris GS115 is selected from Pichia pastoris.
3. The high yielding pichia glutathione strain G3-SF according to claim 1, wherein: the nucleotide sequences of the glutathione synthetase Scgsh1 and Scgsh2 genes, the adenosine kinase Scadk1 gene and the bifunctional enzyme StgshF gene are respectively shown as SEQ.NO.01-SEQ.NO. 04.
4. The construction method of the high-yield glutathione Pichia pastoris G3-SF according to claim 1, characterized in that: taking pichia as a host, firstly heterologously expressing glutathione synthetase Scgsh1 and Scgsh2 genes from saccharomyces cerevisiae, and obtaining an engineering bacterium named as G3; and then G3 is taken as a host, an adenosine kinase Scadk1 gene from saccharomyces cerevisiae and a codon-optimized StgshF gene from streptococcus sanguis are heterologously expressed, and the obtained engineering bacteria are named as pichia pastoris strain G3-SF.
5. The construction method of the Pichia pastoris strain G3-SF for high yield of glutathione according to claim 4, characterized in that: the specific method is that pGAPZA is taken as an initial plasmid, Bgl II and BamH I are adopted for enzyme digestion, and a fragment inserted with Xba I is inserted into the initial plasmid, and the constructed plasmid is named as pGAPZT; inserting P between BglII and Xba I of pGAPZTAOX1A sequence; the Scadk1 gene is obtained after PCR amplification of S.cerevisiae BY4741 genome, and the StgshF gene is synthesized and codon optimized based on the principle of yeast translation optimal codon; the obtained fragments are respectively connected in pGAPZT, expression cassettes of two genes are obtained, then the StgshF gene expression cassette is connected behind the Scadk1 gene expression cassette in series by the principle of isocaudarner connection, SacI is used for linear transformation to a G3 strain, and the obtained strain is screened by a YPD plate containing 2mg/L Zeocin, and the obtained strain is named as G3-SF.
6. The high yield glutathione Pichia pastoris strain G3-SF according to claim 4, which is obtained during the construction method.
7. A gene encoding the high yielding Pichia glutathione yeast strain G3-SF according to any one of claims 1-3.
8. A method for preparing glutathione, which adopts the high-yield Pichia glutathione yeast strain G3-SF according to any one of claims 1-3 or the high-yield Pichia glutathione yeast strain G3-SF constructed according to any one of claims 4-5 to synthesize glutathione by a fermentation method.
9. The method for producing glutathione according to claim 8, wherein: in the fermentation process of the heterologous expression of the adenosine kinase Scadk1 gene and the bifunctional enzyme gene StgshF, 4g/L sodium citrate is exogenously added when the fermentation time is 15-16 h.
10. Glutathione produced according to the method of claim 8 or 9.
CN202110011361.6A 2021-01-06 2021-01-06 High-yield glutathione pichia pastoris strain G3-SF and application thereof Active CN112779173B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110011361.6A CN112779173B (en) 2021-01-06 2021-01-06 High-yield glutathione pichia pastoris strain G3-SF and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110011361.6A CN112779173B (en) 2021-01-06 2021-01-06 High-yield glutathione pichia pastoris strain G3-SF and application thereof

Publications (2)

Publication Number Publication Date
CN112779173A true CN112779173A (en) 2021-05-11
CN112779173B CN112779173B (en) 2023-03-14

Family

ID=75755604

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110011361.6A Active CN112779173B (en) 2021-01-06 2021-01-06 High-yield glutathione pichia pastoris strain G3-SF and application thereof

Country Status (1)

Country Link
CN (1) CN112779173B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717282A (en) * 2021-12-31 2022-07-08 北京盛拓达生物技术有限公司 Composition and application thereof
WO2022185872A1 (en) * 2021-03-01 2022-09-09 長瀬産業株式会社 Ergothioneine production method

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101225402A (en) * 2007-01-16 2008-07-23 上海医药工业研究院 Pichia yeast genetic engineering bacteria for producing glutathione and recombinant plasmid used for constructing the same
CN102071171A (en) * 2009-11-25 2011-05-25 华东理工大学 Bifunctional glutathione synthetase and method for producing glutathione by using same
CN103087932A (en) * 2011-11-03 2013-05-08 镇江市德尔生物制品研究所有限公司 Recombination strain secreting glutathione and preparation method thereof
CN105219823A (en) * 2015-11-10 2016-01-06 深圳市古特新生生物科技有限公司 A kind of enzyme process prepares the method for gsh
CN105238797A (en) * 2015-10-23 2016-01-13 山东金城生物药业有限公司 Mutant gene of gshF genes of streptococcus agalactiae and application thereof
CN105603028A (en) * 2016-03-22 2016-05-25 深圳市古特新生生物科技有限公司 Enzymic method for simultaneously preparing glutathione and adenylate
CN106536744A (en) * 2014-07-29 2017-03-22 株式会社钟化 Method for producing gamma-glutamylcysteine and glutathione
CN108753808A (en) * 2018-05-30 2018-11-06 浙江海正药业股份有限公司 A kind of recombinant expression carrier, recombinant expression host and its method for synthesizing adenosine triphosphoric acid
CN109134594A (en) * 2017-06-15 2019-01-04 深圳市古特新生生物科技有限公司 A kind of method that enzyme process prepares glutathione
CN110603331A (en) * 2017-05-01 2019-12-20 株式会社钟化 Method for producing substance using ATP
CN111662358A (en) * 2019-03-07 2020-09-15 华东理工大学 Method for efficiently synthesizing glutathione by cell-free self-assembly system

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101225402A (en) * 2007-01-16 2008-07-23 上海医药工业研究院 Pichia yeast genetic engineering bacteria for producing glutathione and recombinant plasmid used for constructing the same
CN102071171A (en) * 2009-11-25 2011-05-25 华东理工大学 Bifunctional glutathione synthetase and method for producing glutathione by using same
CN103087932A (en) * 2011-11-03 2013-05-08 镇江市德尔生物制品研究所有限公司 Recombination strain secreting glutathione and preparation method thereof
CN106536744A (en) * 2014-07-29 2017-03-22 株式会社钟化 Method for producing gamma-glutamylcysteine and glutathione
CN105238797A (en) * 2015-10-23 2016-01-13 山东金城生物药业有限公司 Mutant gene of gshF genes of streptococcus agalactiae and application thereof
CN105219823A (en) * 2015-11-10 2016-01-06 深圳市古特新生生物科技有限公司 A kind of enzyme process prepares the method for gsh
CN105603028A (en) * 2016-03-22 2016-05-25 深圳市古特新生生物科技有限公司 Enzymic method for simultaneously preparing glutathione and adenylate
CN110603331A (en) * 2017-05-01 2019-12-20 株式会社钟化 Method for producing substance using ATP
CN109134594A (en) * 2017-06-15 2019-01-04 深圳市古特新生生物科技有限公司 A kind of method that enzyme process prepares glutathione
CN108753808A (en) * 2018-05-30 2018-11-06 浙江海正药业股份有限公司 A kind of recombinant expression carrier, recombinant expression host and its method for synthesizing adenosine triphosphoric acid
CN111662358A (en) * 2019-03-07 2020-09-15 华东理工大学 Method for efficiently synthesizing glutathione by cell-free self-assembly system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
饶志明等: "产谷胱甘肽重组巴斯德毕赤氏酵母发酵条件的研究", 《食品与发酵工业》 *
高宇豪等: "产谷胱甘肽毕赤酵母工程菌的构建及能量调控", 《食品与发酵工业》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022185872A1 (en) * 2021-03-01 2022-09-09 長瀬産業株式会社 Ergothioneine production method
CN114717282A (en) * 2021-12-31 2022-07-08 北京盛拓达生物技术有限公司 Composition and application thereof

Also Published As

Publication number Publication date
CN112779173B (en) 2023-03-14

Similar Documents

Publication Publication Date Title
CA2952709C (en) Production of xylitol from glucose by a recombinant strain
CN112779173B (en) High-yield glutathione pichia pastoris strain G3-SF and application thereof
CN108060114B (en) A kind of Escherichia coli of fermenting and producing l-Alanine and its application
CN112458065B (en) Silybum marianum-derived flavone 3-hydroxylase and application thereof
JP5496356B2 (en) Xylitol producing strain introduced with arabinose metabolic pathway and xylitol producing method using the same
JP2001525682A (en) Transformed microorganism having improved properties
CN113186142A (en) Escherichia coli engineering strain for efficiently producing 2&#39; -fucosyllactose
WO2022174597A1 (en) Genetically engineered bacterium for producing l-sarcosine, construction method therefor and use thereof
Gao et al. Improving glutathione production by engineered Pichia pastoris: Strain construction and optimal precursor feeding
CN112980906B (en) Enzyme composition for preparing beta-nicotinamide mononucleotide and application thereof
CN112646738A (en) High-yield glutathione pichia pastoris strain G3-SA and application thereof
CN114806995B (en) Construction and application of genetically engineered bacterium for efficiently synthesizing tetrahydropyrimidine based on acetyl-CoA metabolic modification
CN114277040B (en) Construction method and application of efficient synthesis beta-carotene strain
CN113897382B (en) Coenzyme self-sufficient escherichia coli and construction method and application thereof
CN112961815B (en) Genetic engineering bacterium for high yield of tetrahydropyrimidine and application thereof
CN116676243A (en) Construction method and application of recombinant escherichia coli producing 2&#39; -fucosyllactose
CN108823258A (en) It is a kind of using full cell as the method for oxidation of catalyst
CN110713967B (en) Escherichia coli with improved levodopa conversion and synthesis efficiency and application thereof
CN110499259B (en) Yarrowia lipolytica YW100-1 and application thereof
CN108913732B (en) Method for heterologous production of monacolin J and application
CN111378587B (en) Genetically engineered bacterium for synthesizing beta-farnesene and application thereof
CN113913355A (en) Genetically engineered bacterium for producing coenzyme Q10 and application thereof
CN112280725A (en) Recombinant escherichia coli for efficiently producing succinic acid and construction method thereof
CN110951766A (en) Method for synthesizing L-ornithine by metabolizing mannitol by using recombinant corynebacterium glutamicum
CN114717250B (en) Method for improving cordycepin yield by modifying cordycepin based on cofactor metabolic engineering strategy and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant